Financials

News Ideas Minds Technicals Forecast

AVBP fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of ArriVent BioPharma, Inc.

Total assets of AVBP for Q1 24 is 327.84 M USD, 101.01% more than the previous Q4 23. And total liabilities decreased by 14.29% in Q1 24 to 10.12 M USD.

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

‪0.00‬

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q3 '23

Q4 '23

Q1 '24

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

YoY growth

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—